Ionetix is engaged in the development, manufacturing, and distribution of a novel class of superconducting cyclotrons for the point-of-care production of PET radioisotopes. With their significantly smaller size, lighter weight, lower power requirement, and lower price point, these systems offer significant advantages over conventional-design